Cryoport, Inc.
Cryoport runs temperature-controlled supply chains for the life sciences, specializing in shipping and storing cell and gene therapies in ultra-cold cryogenic conditions. Its MVE Biological Solutions makes the freezers, dewars, and transport systems, while services like Cryoport Express and BioStorage move and hold these delicate biological materials worldwide. The company was founded in 1999 by six doctors and went public in 2005 through a reverse merger. Its name blends "cryo," for freezing, with "port," a place of arrival and departure.
Granted 1.32M · Sold 691.7K
Granted 149.8K · Sold 93.1K
Granted 12.8K · Sold 8.1K
Granted 231.2K · Sold 228.5K
Granted 43.9K · Sold 13.7K
Granted 46.4K
Granted 47.5K
Granted 149.7K · Sold 119.9K
Granted 96.4K · Sold 51.3K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Shelton JerrellPresident, CEO, Director · 46 transactions | +103.3% | 1.23M | 1.32M | — | 691.7K |
| Zecchini Edward JChief Digital and Tech Officer · 12 transactions | +170.2% | 143.3K | 149.8K | — | 93.1K |
| Berman Richard JDirector · 2 transactions | +4.4% | 112.8Kas of May 2024 | 12.8K | — | 8.1K |
| Stefanovich RobertChief Financial Officer · 20 transactions | -13.6% | 109.8K | 231.2K | — | 228.5K |
| Sawicki Mark WChief Scientific Officer · 14 transactions | +41.9% | 102.4K | 43.9K | — | 13.7K |
| Hancock Daniel MDirector · 3 transactions | +205% | 69.1K | 46.4K | — | — |
| Baddour LindaDirector · 4 transactions | +230.9% | 68.1K | 47.5K | — | — |
| Mandalam RamkumarDirector · 19 transactions | +276.9% | 67.9K | 149.7K | — | 119.9K |
| Hariri Robert JDirector · 14 transactions | +284.8% | 61.6K | 96.4K | — | 51.3K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -1.21M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.